By
Unitaid ,
Cipla
Published: June 12, 2018, 6:44 a.m.·
Tags:
HIV coinfection,
Prevention
Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.
Read More →
By
Cipla
Published: Dec. 6, 2017, 8:04 p.m.·
Tags:
Prevention,
HIV coinfection,
Medicines
Cipla launches Q-TIB globally, a novel fixed dose combination in a single tablet for TB prophylaxis in HIV.
Read More →